01—Abstract
Summary
Summary of the 8-K/A filed April 3, 2024. Cited figures are marked; the original filing is the authoritative source.
This Form 8-K/A supplements SLB's original Form 8-K, filed April 2, 2024, which reported the execution of a merger agreement to acquire ChampionX Corporation.
The amendment adds the Agreement and Plan of Merger, dated April 2, 2024, among Schlumberger N.V., Sodium Holdco, Inc., Sodium Merger Sub, Inc., and ChampionX, as Exhibit 2 under Item 9.01. The merger agreement itself was already incorporated by reference into Item 1.01 of the original report, so this filing mainly makes the full document publicly available. Items 1.01 and 8.01 are otherwise unchanged.
The amendment does not disclose the purchase price, consideration mix, financing terms, or expected synergies. Those details would appear in the merger agreement exhibit, which SLB has partially redacted under Regulation S-K Item 601(b)(2), and in the original report. The filing says the transaction will be structured through a registration statement on Form S-4 that includes a ChampionX proxy statement and an SLB prospectus for the shares to be issued.
Completion depends on ChampionX stockholder adoption of the merger agreement and on securing government regulatory approvals. For investors, the key points are that the deal is a stock-based acquisition of a chemical solutions provider for production and midstream operations, that its closing is subject to ChampionX shareholder approval and regulatory clearance, and that the timing and value terms can only be confirmed from the full agreement and the forthcoming S-4 and proxy materials. Investors should also note the forward-looking risk factors, including integration risk, shifts in oilfield service demand, and macroeconomic and energy transition risks.
02—Key points
Key Highlights
- The 8-K/A adds the full Agreement and Plan of Merger with ChampionX Corporation (dated April 2, 2024) as Exhibit 2; the agreement was already incorporated by reference into the original Item 1.01 disclosure.
- Merger parties include Schlumberger N.V., Sodium Holdco, Inc., Sodium Merger Sub, Inc., and ChampionX Corporation.
- Certain exhibits and schedules to the merger agreement are omitted under Regulation S-K Item 601(b)(2); SLB has agreed to provide them to the SEC on request.
- Completion requires ChampionX stockholders to adopt the merger agreement and the transaction must clear government regulatory approvals.
- SLB intends to file a Form S-4 containing a ChampionX proxy statement and an SLB prospectus for the shares to be issued in the deal.
- The filing does not disclose purchase price, consideration terms, financing, or synergy estimates; these must be found in the merger agreement or the forthcoming S-4.
- Risk factors cited include integration and synergy achievement, deal completion uncertainty, oilfield services demand, commodity price trends, and energy transition.
03—Questions
Frequently Asked Questions
What does this 8-K/A actually add compared with SLB's original April 2, 2024 report?
It adds the full Agreement and Plan of Merger as Exhibit 2 under Item 9.01. The agreement was already incorporated by reference into Item 1.01 of the original report, so the amendment makes the complete document available in the filing itself. Items 1.01 and 8.01 are otherwise unchanged.
Which company is SLB acquiring, and through what structure?
SLB is acquiring ChampionX Corporation through a merger involving Sodium Merger Sub, Inc. and Sodium Holdco, Inc. The filing indicates SLB will issue its own shares in the transaction, which will be registered on Form S-4.
What could prevent the deal from closing?
The filing lists several conditions and risks, including ChampionX stockholder adoption of the merger agreement, government regulatory approvals obtained on the expected terms and timing, the absence of events that could trigger termination, and the ability to integrate the businesses and achieve anticipated synergies. Litigation related to the transaction is also identified as a risk.
Does this filing disclose the deal price or expected synergies?
No. This amendment does not state the purchase price, exchange ratio, financing structure, or synergy targets. Investors should review the merger agreement exhibit (noting that some schedules are omitted) and the Form S-4 and proxy statement/prospectus once filed.
What should investors do next?
Investors should read the Form S-4 and the proxy statement/prospectus when they become available, since they will contain full details on the transaction, its risks, and participant interests. Filings are accessible through the SEC website and SLB's and ChampionX's investor relations sites.
04—Continue